Literature DB >> 19822443

Oxidative mechanisms of IL-4-induced IL-6 expression in vascular endothelium.

Yong Woo Lee1, Won Hee Lee, Paul H Kim.   

Abstract

The present study is designed to investigate the effects of interleukin-4 (IL-4) on expression of interleukin-6 (IL-6), as well as to examine the role of distinct sources of reactive oxygen species (ROS) in this process. Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA) showed that IL-4 significantly up-regulated the mRNA and protein expression of IL-6 in human aortic endothelial cells (HAEC) and C57BL/6 mice. Dihydroethidium (DHE) and dichlorofluorescein (DCF) fluorescence staining demonstrated that IL-4 significantly increased ROS generation in HAEC. A significant and dose-dependent inhibition of IL-4-induced IL-6 expression was observed in HAEC pre-treated with antioxidants, such as pyrrolidine dithiocarbamate (PDTC) and epigallocatechin gallate (EGCG), indicating that IL-4-induced IL-6 expression is mediated via an ROS-dependent mechanism. Additionally, pharmacological inhibitor of NADPH oxidase (NOX) significantly attenuated IL-4-induced ROS generation and IL-6 expression in HAEC. Furthermore, the disruption of NOX gene dramatically and significantly reduced IL-4-induced IL-6 expression in NOX knockout mice (B6.129S6-Cybb(tm1Din)/J). In contrast, overexpression of IL-6 in IL-4-activated HAEC was not affected by inhibiting other ROS generating pathways, such as xanthine oxidase, arachidonic acid metabolism, and the mitochondrial electron transport chain. These results demonstrate that IL-4 up-regulates IL-6 expression in vascular endothelium through NOX-mediated ROS generation. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19822443      PMCID: PMC2808430          DOI: 10.1016/j.cyto.2009.08.009

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  47 in total

Review 1.  Atherosclerosis is an inflammatory disease.

Authors:  R Ross
Journal:  Am Heart J       Date:  1999-11       Impact factor: 4.749

2.  Protective effects of genistein on proinflammatory pathways in human brain microvascular endothelial cells.

Authors:  Yong W Lee; Won H Lee
Journal:  J Nutr Biochem       Date:  2008-05-13       Impact factor: 6.048

3.  Coronary artery superoxide production and nox isoform expression in human coronary artery disease.

Authors:  Tomasz J Guzik; Jerzy Sadowski; Bartlomiej Guzik; Andrew Jopek; Boguslaw Kapelak; Piotr Przybylowski; Karol Wierzbicki; Ryszard Korbut; David G Harrison; Keith M Channon
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-11-17       Impact factor: 8.311

4.  Pro-atherogenic effect of interleukin-4 in endothelial cells: modulation of oxidative stress, nitric oxide and monocyte chemoattractant protein-1 expression.

Authors:  L Walch; L Massade; M Dufilho; A Brunet; F Rendu
Journal:  Atherosclerosis       Date:  2005-10-24       Impact factor: 5.162

5.  Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men.

Authors:  P M Ridker; N Rifai; M J Stampfer; C H Hennekens
Journal:  Circulation       Date:  2000-04-18       Impact factor: 29.690

Review 6.  The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology.

Authors:  Karen Bedard; Karl-Heinz Krause
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

7.  IL-4 stimulates the expression of CXCL-8, E-selectin, VEGF, and inducible nitric oxide synthase mRNA by equine pulmonary artery endothelial cells.

Authors:  Hong Huang; Anouk Lavoie-Lamoureux; Kantuta Moran; Jean-Pierre Lavoie
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-05       Impact factor: 5.464

Review 8.  Redox control of endothelial function and dysfunction: molecular mechanisms and therapeutic opportunities.

Authors:  Shane R Thomas; Paul K Witting; Grant R Drummond
Journal:  Antioxid Redox Signal       Date:  2008-10       Impact factor: 8.401

Review 9.  Role of interleukin-4 in atherosclerosis.

Authors:  Yong Woo Lee; Anjali A Hirani
Journal:  Arch Pharm Res       Date:  2006-01       Impact factor: 4.946

Review 10.  Green tea polyphenols as an anti-oxidant and anti-inflammatory agent for cardiovascular protection.

Authors:  George L Tipoe; Tung-Ming Leung; Ming-Wai Hung; Man-Lung Fung
Journal:  Cardiovasc Hematol Disord Drug Targets       Date:  2007-06
View more
  14 in total

1.  Interleukin-4, Oxidative Stress, Vascular Inflammation and Atherosclerosis.

Authors:  Yong Woo Lee; Paul H Kim; Won Hee Lee; Anjali A Hirani
Journal:  Biomol Ther (Seoul)       Date:  2010-04       Impact factor: 4.634

2.  Role of NADPH oxidase in interleukin-4-induced monocyte chemoattractant protein-1 expression in vascular endothelium.

Authors:  Yong Woo Lee; Won Hee Lee; Paul H Kim
Journal:  Inflamm Res       Date:  2010-03-28       Impact factor: 4.575

3.  Genome-wide approaches reveal functional interleukin-4-inducible STAT6 binding to the vascular cell adhesion molecule 1 promoter.

Authors:  Hideto Tozawa; Yasuharu Kanki; Jun-ichi Suehiro; Shuichi Tsutsumi; Takahide Kohro; Youichiro Wada; Hiroyuki Aburatani; William C Aird; Tatsuhiko Kodama; Takashi Minami
Journal:  Mol Cell Biol       Date:  2011-04-04       Impact factor: 4.272

4.  IL-4 mediated by HSV vector suppresses morphine withdrawal response and decreases TNFα, NR2B, and pC/EBPβ in the periaqueductal gray in rats.

Authors:  H Yi; T Iida; S Liu; D Ikegami; Q Liu; A Iida; D A Lubarsky; S Hao
Journal:  Gene Ther       Date:  2017-03-16       Impact factor: 5.250

Review 5.  Cellular and Oxidative Mechanisms Associated with Interleukin-6 Signaling in the Vasculature.

Authors:  Sean P Didion
Journal:  Int J Mol Sci       Date:  2017-11-29       Impact factor: 5.923

6.  Hypertension and increased endothelial mechanical stretch promote monocyte differentiation and activation: roles of STAT3, interleukin 6 and hydrogen peroxide.

Authors:  Roxana Loperena; Justin P Van Beusecum; Hana A Itani; Noah Engel; Fanny Laroumanie; Liang Xiao; Fernando Elijovich; Cheryl L Laffer; Juan S Gnecco; Jonathan Noonan; Pasquale Maffia; Barbara Jasiewicz-Honkisz; Marta Czesnikiewicz-Guzik; Tomasz Mikolajczyk; Tomasz Sliwa; Sergey Dikalov; Cornelia M Weyand; Tomasz J Guzik; David G Harrison
Journal:  Cardiovasc Res       Date:  2018-09-01       Impact factor: 10.787

7.  Characterization and Significance of Monocytes in Acute Stanford Type B Aortic Dissection.

Authors:  Li Lu; Yuanhao Tong; Wenwen Wang; Yayi Hou; Huan Dou; Zhao Liu
Journal:  J Immunol Res       Date:  2020-05-15       Impact factor: 4.818

Review 8.  The interplay between iron accumulation, mitochondrial dysfunction, and inflammation during the execution step of neurodegenerative disorders.

Authors:  Pamela J Urrutia; Natalia P Mena; Marco T Núñez
Journal:  Front Pharmacol       Date:  2014-03-10       Impact factor: 5.810

9.  Downregulation of blood-brain barrier phenotype by proinflammatory cytokines involves NADPH oxidase-dependent ROS generation: consequences for interendothelial adherens and tight junctions.

Authors:  Keith D Rochfort; Laura E Collins; Ronan P Murphy; Philip M Cummins
Journal:  PLoS One       Date:  2014-07-03       Impact factor: 3.240

10.  10,12 Conjugated Linoleic Acid-Driven Weight Loss Is Protective against Atherosclerosis in Mice and Is Associated with Alternative Macrophage Enrichment in Perivascular Adipose Tissue.

Authors:  Jenny E Kanter; Leela Goodspeed; Shari Wang; Farah Kramer; Tomasz Wietecha; Diego Gomes-Kjerulf; Savitha Subramanian; Kevin D O'Brien; Laura J den Hartigh
Journal:  Nutrients       Date:  2018-10-03       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.